TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Common Equity (2020 - 2025)

Updated

TFA Therapeutics (RAJAF) posted Common Equity of -$534,551 for Q4 2025, compared with -$375,543 a year earlier.

Analysis

TFA Therapeutics (RAJAF) Common Equity (2020 - 2025) Analysis & Trends

Since Q4 2020, TFA Therapeutics has reported Common Equity for 7 quarters.

  • In prior years, TFA Therapeutics' Common Equity was -$375,543 in FY2024, -$151,796 in FY2023, -$951,334 in FY2022 and -$275,813 in FY2021.
  • The Q4 2025 figure stands as the lowest quarterly Common Equity since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn 54.31 Bn
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn 566.00 Mn
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn 10.55 Bn
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn 3.81 Bn
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn 1.87 Bn
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn 4.35 Bn
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn 252.00 Mn
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn 1.17 Bn
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn 2.31 Bn
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -534,551.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -534,551.00
Dec 31, 2024 -375,543.00
Dec 31, 2023 -151,796.00
Sep 30, 2023 -182,939.00
Dec 31, 2022 -951,334.00
Dec 31, 2021 -275,813.00
Dec 31, 2020 -12,812.00
API Access

TFA Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=RAJAF&period=max&api_key=YOUR_API_KEY